Replies to post #830 on Titan Pharmaceuticals Inc (TTNP)

[gimmeshelter]

I'm hoping the same thing. It sure looks that way to me, but many still see this as a $5 stock upon approval; some see it as a $20 stock. I'm no expert, but I could see the latter with Europe and Japan falling in line behind a FDA approval. I'd guess $8-12 for starters, w/approval in US. What do you think? The other day the Street (which has no credibility with me; I still see blowhard cramer spouting off about "hold onto bear stearns") reporter fuhrerstein says Probuphine will get approved but will only be a second-line treatment. With suboxone tablets being pulled next month because of the high abuse factor, it leaves only the suboxone film and methadone, and neither of them is very desirable, especially compared to the abuse-deterrent implant Titan offers. Or am I missing something?